Amrize (NYSE:AMRZ) Rating Lowered to Neutral at JPMorgan Chase & Co.

Amrize (NYSE:AMRZ) was downgraded by equities researchers at JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating in a note issued to investors on Wednesday, Briefing.com reports. They currently have a $52.00 price objective on the stock. JPMorgan Chase & Co.‘s price objective would suggest a potential upside of 21.52% from the stock’s current price.

Other research analysts also recently issued reports about the company. DA Davidson began coverage on Amrize in a report on Monday, August 24th. They set a “neutral” rating and a $50.00 target price on the stock. Citigroup cut their price objective on Amrize from $66.00 to $58.00 and set a “buy” rating on the stock in a research note on Tuesday, August 11th. Bank of America reiterated an “underperform” rating and issued a $40.00 target price (down from $50.00) on shares of Amrize in a report on Wednesday. William Blair set a $40.00 target price on shares of Amrize in a research report on Wednesday. Finally, Stephens lowered their price target on shares of Amrize from $65.00 to $54.00 and set an “overweight” rating for the company in a report on Wednesday, August 12th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have given a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat.com, Amrize has an average rating of “Hold” and a consensus target price of $56.38.

Amrize Trading Down 2.1%

Shares of NYSE AMRZ opened at $42.79 on Wednesday. The firm has a 50 day moving average price of $49.11 and a two-hundred day moving average price of $53.52. The stock has a market cap of $23.67 billion, a P/E ratio of 19.72, a price-to-earnings-growth ratio of 0.97 and a beta of 0.12. Amrize has a 52-week low of $42.72 and a 52-week high of $65.94. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.73 and a current ratio of 1.10.

Amrize (NYSE:AMRZ) last issued its quarterly earnings results on Thursday, August 6th. The company reported $0.88 EPS for the quarter, missing analysts’ consensus estimates of $0.92 by ($0.04). Amrize had a return on equity of 10.22% and a net margin of 9.89%.The business had revenue of $3.49 billion for the quarter. As a group, equities analysts forecast that Amrize will post 2.74 EPS for the current year.

Insider Activity at Amrize

In other Amrize news, Director Jacques Wolf Sanche purchased 4,150 shares of the company’s stock in a transaction on Wednesday, August 26th. The shares were purchased at an average cost of $45.02 per share, with a total value of $186,833.00. Following the completion of the purchase, the director owned 9,766 shares in the company, valued at $439,665.32. This represents a 73.90% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Mario Gross purchased 3,568 shares of the company’s stock in a transaction on Tuesday, August 11th. The stock was acquired at an average cost of $46.60 per share, for a total transaction of $166,268.80. Following the completion of the purchase, the insider owned 38,485 shares of the company’s stock, valued at approximately $1,793,401. This trade represents a 10.22% increase in their position. The SEC filing for this purchase provides additional information. Insiders have purchased 18,983 shares of company stock worth $884,535 over the last quarter. 0.54% of the stock is owned by company insiders.

Institutional Trading of Amrize

Several hedge funds have recently modified their holdings of the stock. MCF Advisors LLC acquired a new position in shares of Amrize during the 4th quarter valued at $27,000. Basepoint Wealth LLC bought a new position in Amrize during the fourth quarter worth $33,000. Itau Unibanco Holding S.A. grew its holdings in Amrize by 150.0% in the fourth quarter. Itau Unibanco Holding S.A. now owns 750 shares of the company’s stock worth $41,000 after purchasing an additional 450 shares during the period. US Bancorp DE bought a new stake in Amrize in the third quarter valued at $38,000. Finally, Caitong International Asset Management Co. Ltd increased its stake in Amrize by 141.3% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 847 shares of the company’s stock valued at $46,000 after purchasing an additional 496 shares in the last quarter.

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.